ReviewBMC oral health2025
Rational utilization of antibiotic prophylaxis in oral and maxillofacial surgery: a large scope review of recent data.
Review in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurgical site infections raise the risk of serious health issues following oral and maxillofacial surgeries. There is full consensus that using systemic antibiotics as a prophylactic measure can reduce infection risk in oral and maxillofacial surgical procedures, but the optimal duration and effective usage of these antibiotics remains debated. In light of growing antibiotic resistance, prophylactic use of antibiotics should be evaluated carefully and limited to certain scenarios. Thus, the aim of this scoping review was to summarize the available data regarding the prudent and evidence-based application of prophylactic antibiotics in the realm of oral and maxillofacial surgical interventions.
methodsA comprehensive literature search was conducted using published studies from 2000 to 2025 across the Ovid MEDLINE, PubMed, Web of Science, Embase, and Google Scholar databases. We included 25 randomized controlled trials, 60 cohort studies, and 40 systematic reviews.
resultsAccording to the included articles, infection rates ranged from 0% to 62% depending on surgery type. Moreover, various antibiotic types and regimens were used, and in most studies, the follow-up period was short, and the outcomes were not clearly defined. The choice of prophylactic antibiotics depends on the specific surgical procedure and the level of contamination involved. The use of prophylactic antibiotics is advised for surgical extractions of third molars, temporomandibular joint replacements, and clean-contaminated tumor removal surgeries. In compound fractures of the mandible, maxillofacial fractures, and those communicating with paranasal sinuses, prescribing a postoperative course of antibiotics for at least 24 h is necessary, but extended use doesn’t lower infection rates. For dental implants, the evidence supporting prophylaxis in healthy individuals is weak. Prophylactic antibiotics are not routinely advised for fractures of the upper or midfacial thirds.
conclusionThe included studies exhibited substantial differences in design and objectives, making direct comparisons challenging. The findings underscore the importance of short-course, targeted prophylaxis over prolonged empirical regimens to curb resistance. Attention to antimicrobial stewardship and strict adherence to guidelines for antibiotic prophylaxis in oral and maxillofacial surgery are essential to reduce antibiotic misuse and improve the quality of study. More studies are required to provide recommendations for maxillofacial surgical interventions in immunocompromised patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.